{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:52:06Z","timestamp":1793742726142,"version":"4.6.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119740","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:43:29Z","timestamp":1783323809000},"page":"119740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From DNA-encoded library (DEL) screening to in vivo validation: LILRB4 (ILT3)-targeted small molecules reprograms myeloid immune suppression"],"prefix":"10.1016","volume":"201","author":[{"given":"Somaya A.","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9074-3331","authenticated-orcid":false,"given":"Moustafa T.","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2026.119740_bib1","article-title":"Alzheimer\u2019s disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.biopha.2026.119740_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119740_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease (CLARITY AD)","volume":"388","author":"van Dyck","year":"2023","journal-title":"New. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119740_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer\u2019s disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2026.119740_bib5","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119740_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003426","article-title":"Disease-associated microglia in neurodegenerative diseases: friend or foe?","volume":"23","author":"Cheng","year":"2025","journal-title":"PLoS. Biol."},{"key":"10.1016\/j.biopha.2026.119740_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00109-024-02504-x","article-title":"The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer\u2019s disease","volume":"103","author":"Salminen","year":"2025","journal-title":"J. Mol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119740_bib8","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2026.119740_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202717","article-title":"Microglia in Alzheimer\u2019s disease at single-cell level. Are there common patterns in humans and mice?","volume":"218","author":"Chen","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119740_bib10","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","article-title":"Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease","volume":"11","author":"Olah","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119740_bib11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1021\/acsmedchemlett.5c00542","article-title":"AI-assisted discovery and optimization of small-molecule TREM2 agonists with functional microglial activity","volume":"17","author":"Cho","year":"2026","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2026.119740_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500718","article-title":"Structure-based virtual screening identifies TREM2-targeted small molecules that enhance microglial phagocytosis","volume":"21","author":"Cho","year":"2026","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2026.119740_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118862","article-title":"As48, a first-in-class dual-function TREM2 modulator: receptor activation and shedding inhibition","volume":"193","author":"Cho","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119740_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118358","article-title":"TREM2 activation by first-in-class direct small molecule agonists: DEL screening, optimization, biophysical validation, and functional characterization","volume":"302","author":"Nada","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2026.119740_bib15","doi-asserted-by":"crossref","first-page":"18013","DOI":"10.1074\/jbc.M111.221028","article-title":"Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3\/LIR-5\/CD85k)","volume":"286","author":"Cheng","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119740_bib16","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/biology10121300","article-title":"Characterization of the Leucocyte Immunoglobulin-like Receptor B4 (Lilrb4) Expression in Microglia","volume":"10","author":"Kretzschmar","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.biopha.2026.119740_bib17","article-title":"Leukocyte immunoglobulin-like receptor B4: a keystone in immune modulation and therapeutic target in cancer and beyond","volume":"3","author":"Lu","year":"2024","journal-title":"Cancer Innov."},{"key":"10.1016\/j.biopha.2026.119740_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-024-03206-4","article-title":"Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment","volume":"21","author":"Ma","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2026.119740_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"5123","key":"10.1016\/j.biopha.2026.119740_bib20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119740_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia","volume":"628","author":"Haney","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2026.119740_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"issue":"741","key":"10.1016\/j.biopha.2026.119740_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj9052","article-title":"Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model","volume":"16","author":"Hou","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119740_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrd.2016.213","article-title":"DNA-encoded chemistry: enabling the deeper sampling of chemical space","volume":"16","author":"Goodnow","year":"2017","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"9","key":"10.1016\/j.biopha.2026.119740_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41573-023-00713-6","article-title":"Small-molecule discovery through DNA-encoded libraries","volume":"22","author":"Peterson","year":"2023","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119740_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-0716-2545-3_23","article-title":"Analysis of DNA-encoded library screening data: selection of molecules for synthesis","volume":"2541","author":"Satz","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119740_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.apsb.2023.10.001","article-title":"Evolution of chemistry and selection technology for DNA-encoded library","volume":"14","author":"Ma","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"17","key":"10.1016\/j.biopha.2026.119740_bib28","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1021\/acs.accounts.1c00375","article-title":"Evolution of the selection methods of DNA-encoded chemical libraries","volume":"54","author":"Song","year":"2021","journal-title":"Acc. Chem. Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119740_bib29","first-page":"841","article-title":"DNA-compatible chemistry for DNA-encoded libraries and beyond","volume":"7","year":"2025","journal-title":"Trends Chem."},{"key":"10.1016\/j.biopha.2026.119740_bib30","article-title":"Splint RNA-mediated single-stranded DNA-encoded library construction and label-free live-cell selection","author":"Li","year":"2026","journal-title":"Chem"},{"issue":"34","key":"10.1016\/j.biopha.2026.119740_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202511839","article-title":"Rational design strategies in DNA-encoded libraries for drug discovery","volume":"64","author":"Wang","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2026.119740_bib32","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1039\/D5CC02904J","article-title":"Recent advances in DNA-encoded libraries","volume":"61","author":"Gao","year":"2025","journal-title":"Chem. Commun."},{"issue":"21","key":"10.1016\/j.biopha.2026.119740_bib33","article-title":"A small molecule selected from a DNA-encoded library of natural products that binds to TNF-\u03b1 and attenuates inflammation in vivo","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci."},{"issue":"35","key":"10.1016\/j.biopha.2026.119740_bib34","doi-asserted-by":"crossref","first-page":"24638","DOI":"10.1021\/jacs.4c08624","article-title":"Agonist discovery for membrane proteins on live cells by using DNA-encoded libraries","volume":"146","author":"Huang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.biopha.2026.119740_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101197","article-title":"Selection of small molecules that bind to and activate the insulin receptor from a DNA-encoded library of natural products","volume":"23","author":"Xie","year":"2020","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.biopha.2026.119740_bib36","first-page":"6587","article-title":"Discovery of small molecule interleukin 17A Inhibitors with novel binding mode and stoichiometry: optimization of DNA-encoded chemical library hits to in vivo active compounds","volume":"67","author":"Lucas","year":"2024","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2026.119740_bib37","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/acsmedchemlett.5c00502","article-title":"A novel small molecule allosteric inhibitor of IL-17A from a DNA-encoded library","volume":"16","author":"Milla","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119740_bib38","article-title":"Discovery and optimization of small molecule inhibitors of the SLIT2\/ROBO1 protein-protein interaction using DNA-encoded libraries","volume":"17","author":"Garcia-Vazquez","year":"2026","journal-title":"Eur. J. Med. Chem. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:45:50Z","timestamp":1784529950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S0753332226007766"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119740","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From DNA-encoded library (DEL) screening to in vivo validation: LILRB4 (ILT3)-targeted small molecules reprograms myeloid immune suppression","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119740"}}